|Description||AVB-S6-500 is a GAS6-AXL signaling pathway blocker with high affnity for GAS6. AVB-S6-500 is developed for the treatment of cancer and nonmalignant fibrotic conditions as a drug candidate. It is in a phase I clinical trial for its safety and tolerability study.|
|Brife Description||GAS6-AXL signaling pathway blocker|
|Application||potential treatment of cancer and nonmalignant fibrotic conditions|
|Current Developer||Aravive Biologics; WuXi Biologics|
PKR-IN-2 is a pyruvate kinase (PKR) activator. IC50: PKR (R510Q) ＜100 nM
[Glu1]-Fibrinopeptide B human
[Glu1]-Fibrinopeptide B, generated from fibrinopeptide B amino acid residues 1-14, is used as a mass spec (MS) standard in proteomic research.
P21d hydrochloride is a breast tumor kinase inhibitor with IC50 value of 30 nM. It can restore E-cadherin expression and suppress migration in breast cancer cel...
PD-116152 is a novel and highly substituted phenazine. It has antitumor activity. It was isolated from the culture broth of a Streptomyces sp.
Propylhexedrine Hydrochloride is an α-adrenergic sympathomimetic amine. It acts as a local vasoconstrictor. It is a stimulant drug that is used medicinally as a...
BPD-Ring B is a product from the synthesis of verteporfinin. It can be used for making porphyrin-related dye, nanoparticles, photosensitizers, and other photody...
APC-366, an amino acid derivative, has been found to be a mast cell tryptase inhibitor and was once studied against asthma by Celera Genomics Group. Ki: 7.1 μM.
Retinyl-β-D-glucoside is a naturally occurring and biologically active metabolites of vitamin A, which are found in fish and mammals.